GSK Sees Progress On Three Regulatory Filings
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA accepts BLA for combination pediatric vaccine and grants priority review for an oral form of Hycamtin for SCLC.
You may also be interested in...
FDA Clears GSK's Combo Vaccine For Kids
Four-in-one shot means fewer needle sticks, same protection.
FDA Clears GSK's Combo Vaccine For Kids
Four-in-one shot means fewer needle sticks, same protection.
GSK’s Oral Hycamtin Will Launch In 2008
Capsules will be the first oral single agent chemotherapy for treatment of small cell lung cancer after failure of a first-line therapy.